CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF
申请人:Millennium Pharmaceuticals, Inc.
公开号:US20160031908A1
公开(公告)日:2016-02-04
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by:
or physiologically acceptable salt thereof.